Analyst Price Targets — ZTS
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| August 25, 2026 11:40 am | — | Cantor Fitzgerald | $94.00 | $77.17 | StreetInsider | Zoetis Inc. (ZTS) PT Lowered to $94 at TD Cowen |
| August 20, 2026 11:14 am | Jonathan Block | Stifel Nicolaus | $80.00 | $76.68 | TheFly | Zoetis price target lowered to $80 from $85 at Stifel |
| August 7, 2026 1:52 pm | — | Morgan Stanley | $85.00 | $75.30 | TheFly | Zoetis price target lowered to $85 from $99 at Morgan Stanley |
| July 27, 2026 12:51 pm | — | UBS | $85.00 | $76.52 | TheFly | Zoetis price target lowered to $85 from $99 at UBS |
| July 22, 2026 12:20 pm | — | Morgan Stanley | $99.00 | $75.50 | TheFly | Zoetis price target lowered to $99 from $115 at Morgan Stanley |
| July 6, 2026 2:26 pm | — | HSBC | $95.00 | $74.63 | TheFly | Zoetis price target lowered to $95 from $140 at HSBC |
| July 1, 2026 9:59 am | — | Barclays | $85.00 | $71.91 | TheFly | Zoetis price target lowered to $85 from $136 at Barclays |
| June 26, 2026 11:17 am | — | Stifel Nicolaus | $85.00 | $77.82 | TheFly | Zoetis price target lowered to $85 from $95 at Stifel |
| May 22, 2026 10:48 am | — | Stifel Nicolaus | $95.00 | $80.06 | TheFly | Zoetis price target lowered to $95 from $105 at Stifel |
| May 15, 2026 12:29 pm | Erin Wright | Morgan Stanley | $115.00 | $76.06 | TheFly | Zoetis price target lowered to $115 from $160 at Morgan Stanley |
Latest News for ZTS
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis Inc. (NYSE:ZTS) today announced that Kristin Peck, Chief Executive Officer, and Jay Saccaro, EVP, Chief Financial Officer and Chief Operating Officer, will participate in a fireside chat at the Morgan Stanley 24th Annual Global Healthcare Conference on Monday, September 14, 2026 at 1:50 p.m. ET. Interested parties can access the live audio webcast of…
Phibro Animal Health's Zoetis MFA acquisition has created a larger animal health platform with stronger earnings and broader manufacturing reach. Vaccines, nutritional specialties, and companion-animal expansion give PAHC newer growth verticals beyond the legacy MFA franchise. Management's optimization program and Chicago Heights consolidation could improve efficiency as the acquired portfolio moves beyond…
Blackhill Capital Inc. cut its stake in shares of Zoetis Inc. (NYSE: ZTS) by 28.8% in the undefined quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 68,296 shares of the company's stock after selling 27,603 shares during the quarter. Zoetis accounts
These stocks have been generous with their dividend increases, and more may be on the way.
Zoetis is navigating the worst drawdown in its stock history, driven by weakening U.S. vet clinic traffic and heightened competition across key companion animal franchises. Despite aggressive competitor promotions, Zoetis protects industry-leading profitability (35%–37% EBIT margins) using targeted gross-to-net rebates rather than base list-price cuts. Trading at a historic low 12x P/E and a 7%+ FCF yield, Zoetis…
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
Senate Trading Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
U.S. House Trading
House Trades Disclosures
| Name | Transaction Date | Type | Asset | Amount | Link |
|---|
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.